Rascol O - Search Results

1

Effect of food on the pharmacokinetics of ropinirole in parkinsonian patients.

Brefel C, Thalamas C, Rayet S, Lopez-Gil A, Fitzpatrick K, Bullman S, Citerone DR, Taylor AC, Montastruc JL, Rascol O. Brefel C, et al. Among authors: rascol o. Br J Clin Pharmacol. 1998 Apr;45(4):412-5. doi: 10.1046/j.1365-2125.1998.t01-1-00704.x. Br J Clin Pharmacol. 1998. PMID: 9578193 Free PMC article. Clinical Trial.

2

A placebo-controlled study of ropinirole, a new D2 agonist, in the treatment of motor fluctuations of L-DOPA-treated parkinsonian patients.

Rascol O, Lees AJ, Senard JM, Pirtosek Z, Brefel C, Montastruc JL, Fuell D. Rascol O, et al. Adv Neurol. 1996;69:531-4. Adv Neurol. 1996. PMID: 8615176 Clinical Trial. No abstract available.

3

Ropinirole in the treatment of levodopa-induced motor fluctuations in patients with Parkinson's disease.

Rascol O, Lees AJ, Senard JM, Pirtosek Z, Montastruc JL, Fuell D. Rascol O, et al. Clin Neuropharmacol. 1996 Jun;19(3):234-45. doi: 10.1097/00002826-199619030-00005. Clin Neuropharmacol. 1996. PMID: 8726542 Clinical Trial.

4

Lack of pharmacokinetic interaction between ropinirole and theophylline in patients with Parkinson's disease.

Thalamas C, Taylor A, Brefel-Courbon C, Eagle S, Fitzpatrick K, Rascol O. Thalamas C, et al. Among authors: rascol o. Eur J Clin Pharmacol. 1999 Jun;55(4):299-303. doi: 10.1007/s002280050632. Eur J Clin Pharmacol. 1999. PMID: 10424323 Clinical Trial.

5

[Role of dopaminergic agonists].

Rascol O, Montastruc JL. Rascol O, et al. Rev Neurol (Paris). 2000;156 Suppl 2 Pt 2:98-104. Rev Neurol (Paris). 2000. PMID: 10916043 Review. French.

6

Naloxone or haloperidol but not yohimbine reverse apomorphine-induced respiratory depression.

Montastruc JL, Rascol O, Montastruc P. Montastruc JL, et al. Among authors: rascol o. Clin Neuropharmacol. 1992 Oct;15(5):404-7. doi: 10.1097/00002826-199210000-00009. Clin Neuropharmacol. 1992. PMID: 1423340

7

Sublingual apomorphine in Parkinson's disease: a clinical and pharmacokinetic study.

Montastruc JL, Rascol O, Senard JM, Gualano V, Bagheri H, Houin G, Lees A, Rascol A. Montastruc JL, et al. Among authors: rascol a, rascol o. Clin Neuropharmacol. 1991 Oct;14(5):432-7. doi: 10.1097/00002826-199110000-00007. Clin Neuropharmacol. 1991. PMID: 1742752

8

Subcutaneous apomorphine increases regional cerebral blood flow in parkinsonian patients via peripheral mechanisms.

Sabatini U, Rascol O, Celsis P, Houin G, Rascol A, Marc-Vergnes JP, Montastruc JL. Sabatini U, et al. Among authors: rascol a, rascol o. Br J Clin Pharmacol. 1991 Aug;32(2):229-34. doi: 10.1111/j.1365-2125.1991.tb03886.x. Br J Clin Pharmacol. 1991. PMID: 1931472 Free PMC article.

9

Cardiovascular effects of central injection of acetylcholine in anaesthetized dogs: a role for vasopressin release.

Rascol O, Montastruc JL, Gauquelin G, Tran MA, Geelen G, Gharib C, Montastruc P. Rascol O, et al. Br J Pharmacol. 1990 Jul;100(3):471-6. doi: 10.1111/j.1476-5381.1990.tb15831.x. Br J Pharmacol. 1990. PMID: 2143957 Free PMC article.

10

[Comparison of bromocriptine and levodopa as first line treatment of Parkinson's disease: results of a 3-year prospective randomized study].

Montastruc JL, Rascol O, Rascol A. Montastruc JL, et al. Among authors: rascol a, rascol o. Rev Neurol (Paris). 1990;146(2):144-7. Rev Neurol (Paris). 1990. PMID: 2181588 Clinical Trial. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

586 results

Search Page